πŸ‡ΊπŸ‡Έ FDA
Patent

US 9707230

Activators of human pyruvate kinase

granted A61KA61K31/445A61K31/495

Quick answer

US patent 9707230 (Activators of human pyruvate kinase) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jul 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Jul 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K31/445, A61K31/495, A61K31/496, A61K31/5025